Introduction {#s0001}
============

Management of type-2 diabetes mellitus (T2DM) has become an increasingly important task because of the increasing numbers of T2DM patients, as reported by the WHO[@CIT0001]. Multiple pharmacotherapies have been developed to date[@CIT0002]^,^[@CIT0003], and of these available treatments, GLP-1 receptor agonists and DPP-4 inhibitors have been developed relatively recently which target the incretin system[@CIT0004].

DPP-4 is the enzyme responsible for the degradation of GLP-1. Use of a DPP-4 inhibitor extends the half-life of native GLP-1, which is as short as 1--2 min under normal physiological conditions[@CIT0005] and therefore permits GLP-1 to restore insulin secretion in T2DM patients, thereby ameliorating their hyperglycaemia. The effect of DPP-4 inhibitors is analogous to that of the use of GLP-1 receptor agonists. However, their chemical nature differs, with GLP-1 receptor agonists being peptide-based, while DPP-4 inhibitors are usually small molecules[@CIT0004]. Because of this, DPP-4 inhibitors can be administered to patients as orally available drugs.

The oral availability of DPP-4 inhibitors also implies that this class of bioactive compound may be a candidate for discovery in food or plants[@CIT0006]^,^[@CIT0007]. We are engaged in evaluating the potential for DPP-4 inhibition by plant-derived substances[@CIT0008], and in this communication, 13 plant samples were evaluated for DPP-4 inhibitory activity. *Eucalyptus globulus* was screened for active compounds and macrocarpals were isolated and identified as DPP-4 inhibitors. Among them, macrocarpal C, which is previously reported to have an antibacterial effect[@CIT0009] and to inhibit human immunodeficiency virus reverse transcriptase activity[@CIT0010], showed a characteristic inhibition curve indicating a distinct inhibitory character from other macrocarpals.

Methods {#s0002}
=======

Isolation of macrocarpals A-C {#s0003}
-----------------------------

Twenty gram of *E. globulus* leaves were extracted by methanol and partitioned in chloroform/methanol/water in the v/v ratios 4:1:5 to yield 2.85 g extract. This was then separated by silica-gel column chromatography (stepwise elution with hexane/ethyl acetate in the ratios 50:1, 20:1, 10:1, 1:1 and 0:1, and then with methanol alone) to obtain fractions (Fr.) 1--6. Fr. 5 (362 mg), eluted by ethyl acetate, was subsequently separated by silica gel column chromatography (stepwise elution with chloroform/methanol in the ratios 20:1, 10:1, 1:1 and 0:1), preparative TLC (using chloroform/methanol 10:1), and by HPLC \[InertSustain C8 (GL Science Co.), gradient elution from 70% methanol/30% water to methanol in 60 min\] to obtain 2,4,6-trihydroxy-5-((*R*)-3-methyl-1-((1a*R*,4a*R*,7 *S*,7a*R*,7b*R*)-1,1,7-trimethyl-4-methylenedecahydro-1*H*-cyclopropa\[e\]azulen-7-yl)butyl)isophthalaldehyde (synonym: macrocarpal C, 1.8 mg). Fr 6 (757 mg), eluted using methanol, was separated by silica-gel column chromatography (first using chloroform/methanol 20:1 containing 1% acetic acid and second using chloroform/methanol 40:1 containing 1% acetic acid), preparative TLC (chloroform/ethyl acetate 3:1 containing 1% acetic acid) and by HPLC \[InertSustain C8 (GL Science Co.), gradient elution from 70% methanol/30% water to methanol in 60 min\] to obtain 2,4,6-trihydroxy-5-((*R*)-1-((1a*R*,4 *R*,4a*R*,7 *S*,7a*S*,7b*R*)-4-hydroxy-1,1,4,7-tetramethyldecahydro-1*H*-cyclopropa\[e\]azulen-7-yl)-3-methylbutyl)isophthalaldehyde (synonym: macrocarpal A, 3.1 mg) and 2,4,6-trihydroxy-5-((*S*)-1-((1a*R*,4 *R*,4a*R*,7 *S*,7a*S*,7b*R*)-4-hydroxy-1,1,4,7-tetramethyldecahydro-1*H*-cyclopropa\[e\]azulen-7-yl)-3-methylbutyl)isophthalaldehyde (synonym: macrocarpal B, 5.4 mg).

DPP-4 inhibitory activity assay {#s0004}
-------------------------------

DPP-4 inhibitory activity was measured using human DPP-4 (Sigma-Aldrich Co.)[@CIT0011]. The samples, DPP-IV enzyme and the substrate were mixed and incubated for 30 min at 37 °C. The liberated product was quantified using LC-MS to calculate the inhibitory activity (See [supporting material for detail](https://doi.org/10.1080/14756366.2017.1396458)). The experiments were carried out in triplicate and representative results are shown in the Figures.

Results and discussion {#s0005}
======================

Screening and isolation of DPP-4 inhibitors from *E. Globulus* {#s0006}
--------------------------------------------------------------

Methanol extracts of 13 plant samples were evaluated for their DPP-4 inhibitory activity: *Acer nikoense* branch 15%, *Angelica keiskei* leaf 33%, *Apocynum venetum* leaf 38%, *Citrus limon* pericarp 30%, *Citrus sinensis* pericarp 20%, *E. globulus* leaf 65%, *Glycyrrhiza uralensis* stolon 88%, *Hibiscus sabdariffa* calyx 44%, *Morinda citrifolia* fruit 6%, *Morus alba* leaf 32%, *Myristica fragrans* seed 70%, *Pinus sylvestris* leaf 41% and *Tabebuia impetiginosa* bark 58%. The percentages represent the degree of DPP-4 inhibition measured at the concentration of 0.2 g dry weight/mL for each sample).

*E. globulus* extract was selected for further study and separated using an activity-guided procedure. Repeated separation by normal phase chromatography and reverse phase HPLC yielded macrocarpals A, B and C ([Figure 1](#F0001){ref-type="fig"}), which were identified by NMR and MS analyses, with reference to published data[@CIT0009]^,^[@CIT0010]^,^[@CIT0012].

![Structure of macrocarpals A--C.](IENZ_A_1396458_F0001_B){#F0001}

DPP-4 inhibitory activity of macrocarpals {#s0007}
-----------------------------------------

Macrocarpals A--C were tested for their DPP-4 inhibitory activity ([Figure 2](#F0002){ref-type="fig"}). Although macrocarpals A and B showed modest activity, with 30% inhibition at 500 µM for both compounds, macrocarpal C showed potent activity, with 90% inhibition at 50 µM. The inhibition curve for macrocarpal C differed markedly from those of macrocarpals A and B. For macrocarpals A and B, linear increases in DPP-4 inhibition were observed, while macrocarpal C showed a marked increase in inhibitory activity within a narrow concentration region, exhibiting almost no activity below 30 µM, but potent activity above 35 µM.

![DPP-4 inhibitory activity of macrocarpals A--C M--A: macrocarpal A; M--B: macrocarpal B; M--C: macrocarpal C. Diprotin was used as positive control (30% at 25 µM).](IENZ_A_1396458_F0002_B){#F0002}

The structures of macrocarpals A--C are quite similar; therefore, the binding of the individual molecules to DPP-4 and the associated inhibition curves would not be expected to differ significantly. The threshold for inhibitory activity by macrocarpal C therefore suggests that more than one molecule may be involved in the inhibition, and aggregation was suspected in the first instance.

Assessment for macrocarpal C aggregation {#s0008}
----------------------------------------

To evaluate the tendency for macrocarpal C to form aggregates in solution, the turbidity of solutions of macrocarpals A--C in 10% DMSO, the solvent used for the DPP-4 inhibitory activity assays, were compared. As shown in [Table 1](#t0001){ref-type="table"}, macrocarpal C was the only compound to cause turbidity. However, the conditions for the DPP-4 inhibitory activity assay included pH control by the buffer (pH 8) and under the same conditions, the solution of macrocarpal C remained clear, presumably due to higher solubility of the phenol groups at pH 8 (data not shown). Therefore, NMR and ESI-MS analysis were also undertaken to evaluate the aggregation of macrocarpals A--C.

###### 

Turbidity of macrocarpals A--C dispersed in 10% DMSO.

                  Concentration (µM)                         
  --------------- -------------------- ---- ---- ----- ----- ------
  Compound        0                    10   50   100   500   1000
  macrocarpal A   −1                   −1   0    5     2     13
  macrocarpal B   0                    0    1    1     3     12
  macrocarpal C   1                    0    16   41    349   763

Data are A~600nm~ ×10^3^.

[Figure 3](#F0003){ref-type="fig"} shows the ^1^H-NMR spectra for macrocarpals A--C (100 µM) dissolved in 10% DMSO/20 mM phosphate buffer (pH 8) containing 100 mM sodium chloride. All three compounds possess methyl groups, and on the macrocarpal A and B spectra, these signals are clearly shown within 0.5--1.5 ppm. In contrast, the same signals in macrocarpal C are broader and are not clearly distinguishable from others. In addition, ESI-MS analysis of macrocarpal C yielded a peak at *m*/*z* = 907.54 \[2 M-H\], which was not observed for macrocarpal A and B.

![^1^H-NMR spectrum (500 MHz, 37 °C) of macrocarpals A--C in buffered DMSO solution.](IENZ_A_1396458_F0003_B){#F0003}

Line broadening on NMR is a well-known sign of limited bond rotation[@CIT0013], and ESI-MS represents a soft ionisation mode that gives information about interacting products[@CIT0014]. The broadened NMR signals and the \[2 M-H\] peak observed using ESI-MS analysis therefore suggest the interaction of two or more macrocarpal C molecules under the conditions used for the enzyme reaction, which may help to explain the nature of the inhibition curve obtained for macrocarpal C.

Conclusions {#s0009}
===========

Macrocarpals A--C were identified as DPP-4 inhibitors within *E. globulus*. Macrocarpal C showed the highest activity and demonstrated a characteristic inhibition curve, which is likely the result of self-aggregation of the compound. Inhibition of DPP-4 by this compound is a novel finding, as is the nature of the inhibition curve. This knowledge should be valuable for further study of potential small molecule DPP-4 inhibitors.
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